Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Angiodynamics (ANGO) over the last 14 years, with Q4 2025 value amounting to $7.4 million.

  • Angiodynamics' Treasury Shares changed 0.0% to $7.4 million in Q4 2025 from the same period last year, while for Nov 2025 it was $7.4 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $7.4 million for FY2025, which is 2917.4% up from last year.
  • Angiodynamics' Treasury Shares amounted to $613847.0 in Q4 2025, which was down 9990.0% from $613847.0 recorded in Q3 2025.
  • Over the past 5 years, Angiodynamics' Treasury Shares peaked at $613.8 million during Q4 2024, and registered a low of $370000.0 during Q2 2021.
  • Over the past 5 years, Angiodynamics' median Treasury Shares value was $370.0 million (recorded in 2021), while the average stood at $256.5 million.
  • As far as peak fluctuations go, Angiodynamics' Treasury Shares changed by 0.0% in 2021, and later surged by 2917.4% in 2024.
  • Angiodynamics' Treasury Shares (Quarter) stood at $5.7 million in 2021, then changed by 0.0% to $5.7 million in 2022, then changed by 0.0% to $5.7 million in 2023, then rose by 29.17% to $7.4 million in 2024, then changed by 0.0% to $7.4 million in 2025.
  • Its Treasury Shares stands at $7.4 million for Q4 2025, versus $7.4 million for Q3 2025 and $7.4 million for Q2 2025.